TY - JOUR
T1 - Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-β in human bronchial epithelial cells
AU - Wang, Lixin
AU - Cummings, Rhett
AU - Zhao, Yutong
AU - Kazlauskas, Andrius
AU - Sham, James K.S.
AU - Morris, Andrew
AU - Georas, Steve
AU - Brindley, David N.
AU - Natarajan, Viswanathan
PY - 2003/10/10
Y1 - 2003/10/10
N2 - Lysophosphatidate (LPA) mediates multiple cellular responses via heterotrimeric G protein coupled LPA-1, LPA-2, and LPA-3 receptors. Many G protein-coupled receptors stimulate ERK following tyrosine phosphorylation of growth factor receptors; however, the mechanism(s) of transactivation of receptor tyrosine kinases are not well defined. Here, we provide evidence for the involvement of phospholipase D (PLD) in LPA-mediated transactivation of platelet-derived growth factor receptor-β (PDGF-Rβ). In primary cultures of human bronchial epithelial cells (HBEpCs), LPA stimulated tyrosine phosphorylation of PDGF-Rβ and threonine/tyrosine phosphorylation of ERK1/2. The LPA-mediated activation of ERK and tyrosine phosphorylation of PDGF-Rβ was attenuated by tyrphostin AG 1296, an inhibitor of PDGF-R kinase, suggesting transactivation of PDGF-R by LPA. Furthermore, LPA-, but not PDGF β-chain homodimer-induced tyrosine phosphorylation of PDGF-Rβ was partially blocked by pertussis toxin, indicating coupling of LPA-R(s) to Gi. Exposure of HBEpCs to LPA activated PLD. Butan-1-ol, which acts as an acceptor of phosphatidate generated by the PLD pathway, blocked LPA-mediated transactivation of PDGF-Rβ. This effect was not seen with butan-3-ol, suggesting PLD involvement. The role of PLD1 and PLD2 in the PDGF-Rβ transactivation by LPA was investigated by infection of cells with adenoviral constructs of wild type and catalytically inactive mutants of PLD. LPA activated both PLD1 and PLD2 in HBEpCs; however, infection of cells with cDNA for wild type PLD2, but not PLD1, increased the tyrosine phosphorylation of PDGF-Rβ in response to LPA. Also, the LPA-mediated tyrosine phosphorylation of PDGF-Rβ was attenuated by the catalytically inactive mutant mPLD2-K758R. Infection of HBEpCs with adenoviral constructs of wild type hPLD1, mPLD2, and the inactive mutants of hPLD1 and mPLD2 resulted in association of PLD2 wild type and inactive mutant proteins with the PDGF-Rβ compared with PLD1. These results show for the first time that transactivation of PDGF-Rβ by LPA in HBEpCs is regulated by PLD2.
AB - Lysophosphatidate (LPA) mediates multiple cellular responses via heterotrimeric G protein coupled LPA-1, LPA-2, and LPA-3 receptors. Many G protein-coupled receptors stimulate ERK following tyrosine phosphorylation of growth factor receptors; however, the mechanism(s) of transactivation of receptor tyrosine kinases are not well defined. Here, we provide evidence for the involvement of phospholipase D (PLD) in LPA-mediated transactivation of platelet-derived growth factor receptor-β (PDGF-Rβ). In primary cultures of human bronchial epithelial cells (HBEpCs), LPA stimulated tyrosine phosphorylation of PDGF-Rβ and threonine/tyrosine phosphorylation of ERK1/2. The LPA-mediated activation of ERK and tyrosine phosphorylation of PDGF-Rβ was attenuated by tyrphostin AG 1296, an inhibitor of PDGF-R kinase, suggesting transactivation of PDGF-R by LPA. Furthermore, LPA-, but not PDGF β-chain homodimer-induced tyrosine phosphorylation of PDGF-Rβ was partially blocked by pertussis toxin, indicating coupling of LPA-R(s) to Gi. Exposure of HBEpCs to LPA activated PLD. Butan-1-ol, which acts as an acceptor of phosphatidate generated by the PLD pathway, blocked LPA-mediated transactivation of PDGF-Rβ. This effect was not seen with butan-3-ol, suggesting PLD involvement. The role of PLD1 and PLD2 in the PDGF-Rβ transactivation by LPA was investigated by infection of cells with adenoviral constructs of wild type and catalytically inactive mutants of PLD. LPA activated both PLD1 and PLD2 in HBEpCs; however, infection of cells with cDNA for wild type PLD2, but not PLD1, increased the tyrosine phosphorylation of PDGF-Rβ in response to LPA. Also, the LPA-mediated tyrosine phosphorylation of PDGF-Rβ was attenuated by the catalytically inactive mutant mPLD2-K758R. Infection of HBEpCs with adenoviral constructs of wild type hPLD1, mPLD2, and the inactive mutants of hPLD1 and mPLD2 resulted in association of PLD2 wild type and inactive mutant proteins with the PDGF-Rβ compared with PLD1. These results show for the first time that transactivation of PDGF-Rβ by LPA in HBEpCs is regulated by PLD2.
UR - http://www.scopus.com/inward/record.url?scp=0141925648&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141925648&partnerID=8YFLogxK
U2 - 10.1074/jbc.M302896200
DO - 10.1074/jbc.M302896200
M3 - Article
C2 - 12890682
AN - SCOPUS:0141925648
SN - 0021-9258
VL - 278
SP - 39931
EP - 39940
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 41
ER -